Cubresa's new NuPET scanner enables simultaneous PET/MRI in existing third-party MRI systems

Cubresa's NuPET™ scanner enables simultaneous preclinical molecular and functional imaging. The PET (Positron Emission Tomography) scanner inserts into existing MRI (Magnetic Resonance Imaging) systems and can speed drug development and clarify disease mechanisms for biomedical researchers.

A compact PET scanner called NuPET™ has been commercially released for simultaneous preclinical PET (Positron Emission Tomography) and MRI (Magnetic Resonance Imaging) in existing third-party MRI systems. PET and MRI are complementary imaging methods for better understanding disease and testing novel treatments in small animal subjects. Simultaneous PET/MRI imaging offers a solution to many challenges that face researchers who wish to correlate biochemical and physiological changes in their subjects.

Cubresa Inc., a medical imaging company that develops and markets molecular imaging systems, today announced the release of its NuPET™ scanner and that systems have already been shipped and installed.

“Simultaneous PET/MRI lets us discover new relationships between functional and molecular processes during development of new drugs and disease diagnostics,” says Dr. Steven Beyea, scientific lead for BIOTIC (Biomedical Translational Imaging Centre) at the Izaak Walton Killam Health Centre in Canada. “An example is that with our NuPET™ system, we can now correlate metabolic and vascular changes due to cancer, which will enable us to understand the impact of novel therapeutics.”

Scientists can currently scan their subjects on two separate PET and MRI machines. However, significant challenges such as image registration, changing animal physiology and data obtained at different times can hamper breakthroughs.

“The NuPET™ system will provide scientists with the ability to monitor structural, functional and molecular changes under identical physiological conditions, since changes are observed at the same time,” says George Abe, CEO of Cubresa. “This gives scientists confidence when evaluating multi-modal data, and could potentially reduce the number of animals required to reach scientific conclusions.”

Cubresa will be showcasing the NuPET scanner in Booth 519 at the 24th Annual Meeting of the ISMRM (International Society for Magnetic Resonance in Medicine) in Singapore May 7—13, 2016.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Cubresa Inc.. (2019, June 24). Cubresa's new NuPET scanner enables simultaneous PET/MRI in existing third-party MRI systems. News-Medical. Retrieved on April 26, 2024 from https://www.news-medical.net/news/20160429/Cubresas-new-NuPET-scanner-enables-simultaneous-PETMRI-in-existing-third-party-MRI-systems.aspx.

  • MLA

    Cubresa Inc.. "Cubresa's new NuPET scanner enables simultaneous PET/MRI in existing third-party MRI systems". News-Medical. 26 April 2024. <https://www.news-medical.net/news/20160429/Cubresas-new-NuPET-scanner-enables-simultaneous-PETMRI-in-existing-third-party-MRI-systems.aspx>.

  • Chicago

    Cubresa Inc.. "Cubresa's new NuPET scanner enables simultaneous PET/MRI in existing third-party MRI systems". News-Medical. https://www.news-medical.net/news/20160429/Cubresas-new-NuPET-scanner-enables-simultaneous-PETMRI-in-existing-third-party-MRI-systems.aspx. (accessed April 26, 2024).

  • Harvard

    Cubresa Inc.. 2019. Cubresa's new NuPET scanner enables simultaneous PET/MRI in existing third-party MRI systems. News-Medical, viewed 26 April 2024, https://www.news-medical.net/news/20160429/Cubresas-new-NuPET-scanner-enables-simultaneous-PETMRI-in-existing-third-party-MRI-systems.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study using Cubresa SPECT scanner finds potential non-invasive diagnosis for Alzheimer’s